Corient Private Wealth
TENX icon

Corient Private Wealth’s Tenax Therapeutics TENX Stock Holding History

Corient Private Wealth’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$198K Sell
12,388
-12,388
-50% -$168K ﹤0.01% 2573
2025
Q4 		$302K Buy
+24,776
New +$215K ﹤0.01% 2496
2024
Q1 		– Sell
-2,387
Closed -$52.4K – 2367
2023
Q4 		$52.4K Sell
2,387
-6
-0.3% -$144 ﹤0.01% 2195
2023
Q3 		$56.4K Hold
2,393
– – ﹤0.01% 2069
2023
Q2 		$57.4K Hold
2,393
– – ﹤0.01% 2012
2023
Q1 		$89K Buy
+2,393
New +$250K ﹤0.01% 1899

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Corient Private Wealth's TENX Position: Q1 2026 in Review

Corient Private Wealth reduced its Tenax Therapeutics (TENX) stake by 50% in Q1 2026, selling an estimated $168K and leaving 12,388 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #2573.

Corient Private Wealth first reported a position in TENX in Q1 2023 and has held it in 6 quarters since. The position peaked at $302K in Q4 2025. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Corient Private Wealth held 12,388 shares of Tenax Therapeutics worth $198K as of Q1 2026.
  • Corient Private Wealth sold 12,388 Tenax Therapeutics shares in Q1 2026, an estimated $168K.
  • Tenax Therapeutics made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2573 holding.
  • Corient Private Wealth first reported a position in Tenax Therapeutics in Q1 2023 and has held it in 6 quarters since.
  • Corient Private Wealth's Tenax Therapeutics position peaked at $302K in Q4 2025.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.